ATE498006T1 - Rekombinantes herpesvirus aus truthähnen und seine verwendungen - Google Patents

Rekombinantes herpesvirus aus truthähnen und seine verwendungen

Info

Publication number
ATE498006T1
ATE498006T1 AT06026820T AT06026820T ATE498006T1 AT E498006 T1 ATE498006 T1 AT E498006T1 AT 06026820 T AT06026820 T AT 06026820T AT 06026820 T AT06026820 T AT 06026820T AT E498006 T1 ATE498006 T1 AT E498006T1
Authority
AT
Austria
Prior art keywords
turkeys
herpesvirus
provides
recombinant
region
Prior art date
Application number
AT06026820T
Other languages
English (en)
Inventor
Martha Wild
David E Junker
Mark D Cochran
Philip Singer
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/288,065 external-priority patent/US5961982A/en
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Application granted granted Critical
Publication of ATE498006T1 publication Critical patent/ATE498006T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06026820T 1994-08-09 1995-08-09 Rekombinantes herpesvirus aus truthähnen und seine verwendungen ATE498006T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/288,065 US5961982A (en) 1985-09-06 1994-08-09 Recombinant herpesvirus of turkeys and uses thereof
US08/362,240 US5965138A (en) 1985-09-06 1994-12-22 Recombinant chimeric virus and uses thereof

Publications (1)

Publication Number Publication Date
ATE498006T1 true ATE498006T1 (de) 2011-02-15

Family

ID=26964815

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95930814T ATE350467T1 (de) 1994-08-09 1995-08-09 Rekombinantes herpesvirus aus trufhähnen und seine verwendungen
AT06026820T ATE498006T1 (de) 1994-08-09 1995-08-09 Rekombinantes herpesvirus aus truthähnen und seine verwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95930814T ATE350467T1 (de) 1994-08-09 1995-08-09 Rekombinantes herpesvirus aus trufhähnen und seine verwendungen

Country Status (11)

Country Link
US (1) US5965138A (de)
EP (2) EP0776361B1 (de)
JP (2) JP3756950B2 (de)
AT (2) ATE350467T1 (de)
AU (1) AU711815C (de)
CA (1) CA2196570C (de)
DE (2) DE69536138D1 (de)
DK (1) DK0776361T3 (de)
ES (1) ES2278382T3 (de)
MX (1) MX9700833A (de)
WO (1) WO1996005291A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU629248B2 (en) * 1988-09-13 1992-10-01 Merial Viral vaccines
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US6183753B1 (en) * 1994-08-09 2001-02-06 Schering-Plough Veterinary Corp. Recombinant chimeric virus and uses thereof
US6984728B2 (en) 1993-09-24 2006-01-10 Schering Corporation Recombinant infectious laryngotracheitis virus and uses thereof
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
DE69836557T2 (de) * 1997-10-03 2007-09-20 Zeon Corp. Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden
US6506385B1 (en) 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
US6299882B1 (en) * 1999-04-09 2001-10-09 Schering Corporation UL54.5 of Marek's disease virus (MDV)
JP2003528587A (ja) * 1999-10-29 2003-09-30 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ２７個のヒト分泌タンパク質
US6516246B2 (en) * 2000-09-11 2003-02-04 Mimicking Man Manually, Inc. Method and system for determining native neurological dominant hemisphere
US7314715B2 (en) * 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
US6764684B2 (en) 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
AU2003239589A1 (en) 2002-05-24 2003-12-12 Schering-Plough Ltd. Eta-1 gene and methods for use
WO2005049846A2 (en) 2003-11-17 2005-06-02 Crusade Laboratories Limited Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer
GB0326798D0 (en) 2003-11-17 2003-12-24 Crusade Lab Ltd Methods for generating mutant virus
US7897146B2 (en) 2003-11-17 2011-03-01 Crusade Laboratories Limited Treatment using herpes simplex virus
CA2603944C (en) * 2005-04-08 2015-06-23 Bayer Bioscience N.V. Elite event a2704-12 comprising the integration of the phosphinothricin acetyltransferase (pat) gene into soybeans, and methods and kits for identifying such event in biological samples
US20080241188A1 (en) 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
JP2011525519A (ja) * 2008-06-23 2011-09-22 インターベツト・インターナシヨナル・ベー・ベー インターロイキン１２をコードするシチメンチョウの組換えヘルペスウイルス
US9089360B2 (en) 2008-08-06 2015-07-28 Ethicon Endo-Surgery, Inc. Devices and techniques for cutting and coagulating tissue
EP2768964B1 (de) 2011-10-21 2018-10-10 Intervet International B.V. Rekombinante nicht-pathogene konstrukte von marek's disease virus, welche antigene von infektiösen laryngotracheitis-virus und newcastle disease virus enthalten
BR112014008161A2 (pt) * 2011-10-21 2017-04-11 Intervet Int Bv vírus da doença de marek não patogênico recombinante, método para a preparação do mesmo, molécula do ácido nucleico, célula hospedeira, vacina para aves domésticas, método para a preparação de uma vacina, uso de um vírus da doença de marek não patogênico recombinante, e, método de vacinação de aves domésticas
EP2644702A1 (de) 2012-03-30 2013-10-02 Ceva Sante Animale Multivalentes rekombinantes Vogelherpesvirus und Impfstoff zur Immunisierung von Vogelarten
AR097029A1 (es) * 2013-07-26 2016-02-17 Intervet Int Bv Aceleración de la respuesta inmune inducida por virus vectorial en aves, composición, uso, método para la vacunación y método para acelerar la respuesta inmune
AR103245A1 (es) 2014-12-24 2017-04-26 Intervet Int Bv Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada
EP3471766B1 (de) 2016-06-17 2022-12-14 Intervet International B.V. Für antigene des virus der infektiösen laryngothracheitis und der infektiösen bursitis codierende nichtpathogene rekombinante morbus-marek-viruskonstrukte
CN117357642A (zh) * 2016-12-14 2024-01-09 勃林格殷格翰动物保健美国公司 表达禽病原体的多种抗原的重组hvt载体及其用途
BR112020007213A2 (pt) 2017-10-12 2020-10-13 Intervet International B.V. construtos de vírus da doença de marek não patogênico recombinante que codificam múltiplos antígenos heterólogos
US11464849B2 (en) 2019-09-11 2022-10-11 Zoetis Services Llc Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
CN114828882A (zh) 2019-12-20 2022-07-29 英特维特国际股份有限公司 多价hvt载体疫苗
CN116472057A (zh) 2020-06-17 2023-07-21 勃林格殷格翰动物保健有限公司 表达流感血凝素的重组hvt载体和免疫原性组合物，以及其生产和用途
JP2024501943A (ja) 2020-12-24 2024-01-17 インターベット インターナショナル ベー． フェー． 多価ｈｖｔベクターワクチン
US20250352642A1 (en) 2022-05-05 2025-11-20 Intervet Inc. New multivalent hvt vector vaccine
KR102758682B1 (ko) * 2024-01-02 2025-02-04 (주)바이오드 전염성 f낭병 항원을 발현하는 키메라 바이러스 및 이를 포함하는 백신 조성물
WO2026013161A1 (en) 2024-07-10 2026-01-15 Boehringer Ingelheim Vetmedica Gmbh Prime and boost vaccination for the treatment and prevention of avian influenza infections in avians
WO2026013162A1 (en) 2024-07-10 2026-01-15 Boehringer Ingelheim Vetmedica Gmbh Herpes virus of turkey vector based h5ha vaccine for the treatment and prevention of avian influenza infections in turkeys

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859587A (en) * 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
US5928648A (en) 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5223424A (en) * 1985-09-06 1993-06-29 Prutech Research And Development Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
US5047237A (en) * 1985-09-06 1991-09-10 Prutech Research And Development Partnership Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
US4877737A (en) * 1985-09-06 1989-10-31 Prutech Research And Development Partnership Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same
EP0351418B1 (de) * 1987-03-19 1995-05-17 Synergen, Inc. Virales vektorsystem zum einführen fremder dns-expressionserzeugnisse in gallinaceenvögeln
JPH02500409A (ja) * 1987-07-27 1990-02-15 シントロ・コーポレイシヨン 弱毒化ヘルペスウイルス、アミノ酸配列コード化外来ｄｎａ含有ヘルペスウイルス並びに同上含有ワクチン
JP2583115B2 (ja) * 1988-09-10 1997-02-19 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
AU629248B2 (en) * 1988-09-13 1992-10-01 Merial Viral vaccines
US5225336A (en) * 1989-03-08 1993-07-06 Health Research Incorporated Recombinant poxvirus host range selection system
EP0431668B1 (de) * 1989-12-04 1995-02-15 Akzo Nobel N.V. Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor
FR2659349B1 (fr) * 1990-03-12 1993-12-24 Rhone Merieux Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus.
ES2056565T3 (es) * 1990-07-30 1994-10-01 Akzo Nobel Nv Virus recombinante de la enfermedad de marek.
US5252717A (en) * 1990-08-24 1993-10-12 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segments encoding glycoproteins, gD, gI and gE
WO1992003554A1 (en) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Infectious laryngotracheitis virus vaccine
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
EP0486106A3 (en) * 1990-11-16 1992-12-23 Akzo N.V. Marek's disease virus vaccine
US5240703A (en) * 1991-03-01 1993-08-31 Syntro Corporation Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
DE69233158T2 (de) * 1991-03-07 2004-05-13 Connaught Technology Corp., Greenville Gentechnologisch hergestellter stamm für impfstoffe
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.

Also Published As

Publication number Publication date
CA2196570C (en) 2010-10-12
ES2278382T3 (es) 2007-08-01
EP1801204B1 (de) 2011-02-09
JPH10506782A (ja) 1998-07-07
JP2006055171A (ja) 2006-03-02
JP4339835B2 (ja) 2009-10-07
AU711815C (en) 2003-02-20
MX9700833A (es) 1997-06-28
JP3756950B2 (ja) 2006-03-22
AU3405395A (en) 1996-03-07
EP1801204A1 (de) 2007-06-27
EP0776361A1 (de) 1997-06-04
WO1996005291A1 (en) 1996-02-22
EP0776361B1 (de) 2007-01-03
CA2196570A1 (en) 1996-02-22
US5965138A (en) 1999-10-12
DE69536138D1 (de) 2011-03-24
AU711815B2 (en) 1999-10-21
ATE350467T1 (de) 2007-01-15
DE69535359D1 (de) 2007-02-15
EP0776361A4 (de) 2003-06-04
DK0776361T3 (da) 2007-04-30
DE69535359T2 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
ATE498006T1 (de) Rekombinantes herpesvirus aus truthähnen und seine verwendungen
CA2196555A1 (en) Vr-2332 viral nucleotide sequence and methods of use
ES2061708T3 (es) Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus.
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
ATE92531T1 (de) Rekombinante herpes simplex-viren, vakzine und verfahren.
CA2660355A1 (en) Polynucleotide vaccine formulation against pathologies of the horse
CA2166367A1 (en) Live recombinant avian vaccine using an avian herpesvirus as vector
DK157087D0 (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
EP0414689A4 (en) Pox virus vectors
EP1026246A4 (de) Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden
DE69735594D1 (de) Rekombinanter schweinepockenvirus
ATE118822T1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
WO2000061736A3 (en) Recombinant and mutant marek's disease virus
US4999296A (en) Thymidine kinase negative insertion mutants of pseudorabies virus and methods for the production of same
EP0294469A4 (de) Impfstoffe und diagnosetest für haemophilus influenzae.
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
DE69929530D1 (de) Attenuierte pferdeherpesvirus
EP0256677A3 (de) Pseudorabiesvirus-Rekombinanten und ihre Verwendung zur Herstellung von Proteinen
EP0432220A4 (en) Vaccines and diagnostic assays for haemophilus influenzae
DE68912478D1 (de) Rekombinantes Marek-Krankheitsvirus, Verfahren zu seiner Herstellung, und Vakzine.
WO1997003187A3 (en) Marek's disease virus genes and their use in vaccines for protection against marek's disease
DE122007000004I1 (de) Attenuierte Herpesviren, Herpesviren die eine Aminosäuresequenz kodierende fremde DNA enthalten, unddiese enthaltende Impfstoffe
DK0606452T3 (da) Vektorvacciner fra rekombinant katteherpesvirus
ATE244308T1 (de) Rekombitante, equine herpesviren
AU686000B2 (en) Infectious peritonitis vaccine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties